Physician

James Cletus Strobel, M.D.

According to 2025 Medicare claims, James Strobel, M.D. (NPI: 1730187998) practices gastroenterology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is GASTROENTEROLOGY HEALTH PARTNERS, PLLC (NPI: 1982963872; TIN: 454217766) and primary practice location at 47150-4053.

Strobel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 980 traditional Medicare patients, billed 8,028 HCPCS/CPT codes, and received $241,898 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,809 prescription claims across 668 beneficiaries totaling $1,082,794 in drug costs, led by Humira(Cf) Pen (Adalimumab). DME data shows 47 claims. Open Payments data shows 30 records totaling $587. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $910,743 to $1,082,794. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $208.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,119	5,335	$221,763
2016	1,060	3,358	$271,494
2017	1,149	8,353	$319,350
2018	1,174	22,998	$402,753
2019	1,151	15,317	$345,599
2020	996	9,200	$282,421
2021	1,045	15,326	$320,758
2022	1,041	11,294	$307,844
2023	1,019	14,460	$348,387
2024	980	8,028	$241,898

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	438	2,653	$910,743
2016	477	3,027	$955,595
2017	496	3,282	$538,054
2018	534	3,373	$679,339
2019	540	3,057	$905,238
2020	548	2,907	$1,127,707
2021	576	3,049	$1,115,439
2022	603	3,080	$1,318,956
2023	626	2,941	$1,612,498
2024	668	2,809	$1,082,794

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	14	$1,401
2022	N/R	13	$166
2023	N/R	29	$1,564
2024	N/R	47	$1,771

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	285	285	$184
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	190	218	$83
43235	Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope	146	158	$75
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	129	132	$72
43450	Dilation of esophagus	128	141	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	47	1,456	$655,776
Linzess	Linaclotide	67	3,690	$66,112
Xifaxan	Rifaximin	11	298	$35,219
Creon	Lipase/Protease/Amylase	19	552	$28,554
Dexlansoprazole Dr	Dexlansoprazole	35	2,671	$9,882

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A5063	Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each	N	N/R	18	$926
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	12	$683
A4456	Adhesive remover, wipes, any type, each	N	N/R	17	$162

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$587	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Cletus Strobel, M.D.?

Tedicare shows public-source Medicare data for James Cletus Strobel, M.D. (NPI 1730187998), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Cletus Strobel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Cletus Strobel, M.D.?

James Cletus Strobel, M.D. is linked to GASTROENTEROLOGY HEALTH PARTNERS, PLLC (billing NPI 1982963872) in the available physician profile data.

Does James Cletus Strobel, M.D. have Open Payments data?

James Cletus Strobel, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.